REGRANEX (SMITH & NEPHEW, INC.)
Welcome to the PulseAid listing for the REGRANEX drug offered from SMITH & NEPHEW, INC.. This Human Platelet-derived Growth Factor [EPC],Platelet-Derived Growth Factor [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | SMITH & NEPHEW, INC. |
| NON-PROPRIETARY NAME: | becaplermin |
| SUBSTANCE NAME: | BECAPLERMIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Platelet-derived Growth Factor [EPC],Platelet-Derived Growth Factor [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2011-11-01 |
| END MARKETING DATE: | 0000-00-00 |
REGRANEX HUMAN PRESCRIPTION DRUG Details:
| Item Description | REGRANEX from SMITH & NEPHEW, INC. |
| LABELER NAME: | SMITH & NEPHEW, INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(ug/g) |
| START MARKETING DATE: | 2011-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50484-810_090ffb2d-8570-4d0b-ac81-c292420c2f2d |
| PRODUCT NDC: | 50484-810 |
| APPLICATION NUMBER: | BLA103691 |
Other BECAPLERMIN Pharmaceutical Manufacturers / Labelers:
